Profil
Christoph Aufricht is the founder of Zytoprotec GmbH, where he holds the title of Chief Scientific Officer since 2007.
He is currently a Professor at the Medical University of Vienna.
Postes actifs de Christoph Aufricht
| Sociétés | Poste | Début |
|---|---|---|
Zytoprotec GmbH
 Zytoprotec GmbH Pharmaceuticals: MajorHealth Technology Zytoprotec GmbH develops and manufactures drugs for peritoneal dialysis. It specializes in the research and development of its pipeline, which encompasses PD-protec, a patented-protected solution and ICO-protec, a cytoprotective PD solution to address the market for non-glucose based PD solutions. The firm focus areas encompass portfolio management, therapeutic approach, patent management and research services. The company was founded by Karl Altenhuber, Christoph Aufricht and Christian Hoenig in 2007 and is headquartered in Vienna, Austria. | Fondateur | 01/01/2007 |
| Medical University of Vienna | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Zytoprotec GmbH
Zytoprotec GmbH Pharmaceuticals: MajorHealth Technology Zytoprotec GmbH develops and manufactures drugs for peritoneal dialysis. It specializes in the research and development of its pipeline, which encompasses PD-protec, a patented-protected solution and ICO-protec, a cytoprotective PD solution to address the market for non-glucose based PD solutions. The firm focus areas encompass portfolio management, therapeutic approach, patent management and research services. The company was founded by Karl Altenhuber, Christoph Aufricht and Christian Hoenig in 2007 and is headquartered in Vienna, Austria. | Health Technology |